AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

News & Events

The Avoca Quality Consortium Summit 2015 Executive Summary

Read the Executive Summary from the 2015 Avoca Quality Consortium Summit here.

Read More

Avoca Quality Consortium Announces 2015 Summit

Clinical Executives Will Convene to Discuss Leading Practices for Bridging Clinical Trial Innovation and Quality at The Avoca Quality Consortium 2015 Summit

Read More

Avoca CEO Patty Leuchten named winner of the 2014 SmartCEO Brava! Award

The Avoca Group CEO, Patricia Leuchten, has been announced a winner of the SmartCEO 2014 Brava! Award. The Brava! Awards celebrate the distinguished achievements of 25 of Greater Philadelphia’s top women business leaders.

Read More Read More

Summit 2014 Executive Summary

View the 2014 Summit Executive Summary here.

Read More

5 Tips For Successfully Outsourcing A Medical Device Clinical Trial

Avoca research on medical device clinical outsourcing trends cited in Med Device Online.

Read More

Over 100 Pharmaceutical Execs Convene in Princeton to Discuss Collaborating to Build Quality into Clinical Trials

Third Annual Avoca Quality Consortium Summit Focuses on New Ways to Break Down Silos, Advance Technology, and Build Bridges to Patients during Clinical Trials

Read More

CROs more than sponsors turning to QbD for clinical research, survey finds

Read More

Shifting Monitoring Paradigms: Challenges and Opportunities

Avoca data cited in Applied Clinical Trials article 'Shifting Monitoring Paradigms: Challenges and Opportunities, Sponsor-site alignment on risk-based approaches is critical if clinical trial standards are to reach new levels.'

Read More

Topic Filters

All  |  None